Profound Medical CORP 8-K filings
NASDAQ
Profound Medical Corp. has announced the Notice of its 2025 Annual and Special Meeting of Shareholders to be held on May 14, 2025, along with the Management Information Circular.
NASDAQ
Profound Medical reports a 108% revenue increase in Q4 2024 compared to Q4 2023, driven by recurring revenue and capital equipment sales, while also announcing an amendment to its credit agreement with CIBC.
NASDAQ
8-K: Profound Medical Announces Strong Preliminary Revenue Growth and Transition to U.S. GAAP Reporting
Profound Medical reports preliminary unaudited revenue growth of 105-110% year-over-year for the fourth quarter of 2024 and announces a transition to U.S. GAAP reporting.